Concepedia

Eline Vermue

EV

Statistics

Publications

5

Citations

95

H-Index

5

Active since

2018

Affiliations

Amsterdam University Medical Centers(Current)

Cancer Center Amsterdam

Amsterdam UMC Location Vrije Universiteit Amsterdam

Eline Vermue is an author at Amsterdam University Medical Centers specializing in medicine, acute myeloid leukemia treatment, and oncology.

ORCID

Publications per year

2018–2023

5

Publications

5

The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor Cells

Noortje van Gils, Tania Martiáñez Canales, Eline Vermue et al. · HemaSphere · 2021 · 33 citations · Full text

, , +17

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression

Margot F. van Spronsen, Diana Hanekamp, Theresia M. Westers et al. · Leukemia · 2023 · 21 citations · Full text

, , +16

IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis

Han Verhagen, Noortje van Gils, Tània Martiáñez et al. · Cell Reports · 2018 · 18 citations · Full text

, , +17

Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters

Noortje van Gils, Han Verhagen, Michaël Broux et al. · iScience · 2022 · 12 citations · Full text

, , +17

IGFBP7 activates retinoid acid–induced responses in acute myeloid leukemia stem and progenitor cells

Noortje van Gils, Han Verhagen, Arjo Rutten et al. · Blood Advances · 2020 · 11 citations · Full text

, , +17

1–5 of 5